MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
13.52
-0.98 (-6.76%)
At close: Oct 14, 2025, 4:00 PM EDT
14.00
+0.48 (3.55%)
After-hours: Oct 14, 2025, 6:02 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $604.55 million as of October 14, 2025. Its market cap has decreased by -26.05% in one year.
Market Cap
604.55M
Enterprise Value
381.42M
1-Year Change
-26.05%
Ranking
Category
Stock Price
$13.52
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $604.55M, an increase of 18.62%. That is a compound annual growth rate of 17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 648.37M | 5.28% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |